Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of 'neuroleptic-free' schizophrenics: Evidence on reversible up-regulation by typical neuroleptics

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2454-2464

  Sokolov, Boris P ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Frontal cortex; Glutamate receptor mRNAs; Neuroleptic; Postmortem; Schizophrenia

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CADAVER; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; LEARNING; MALE; MEMORY; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 0031774346     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062454.x     Document Type: Article

References (54)

1. Akbarian S., Smith M. A., and Jones E. G. (1995) Editing for an AMPA receptor subunit mRNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain Res. 699, 297-304.
2. Akbarian S., Sucher N. J., Bradley D., Tafazzoli A., Trinh D., Hetric W. P., Potkin S. G., Sandman C. A., Bunney W. E. Jr., and Jones E. G. (1996) Selective alterations in gene expression for NMDA receptor subunits in the prefrontal cortex of schizophrenics. J. Neurosci. 16, 19-30.
3. Aparicio-Legarza M. I., Davis B., Hutson P. H., and Reynolds G. P. (1998) Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients. Neurosci. Lett. 241, 143-146.
4. Breese C. R., Freedman R., and Leonard S. S. (1995) Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 674, 82-90.
5. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. Collingridge G. L. and Lester R. A. J. (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40, 143-210.
7. Deakin J. F. W., Slater P., Simpson M. D. C., Gilchrist A. C., Skan W. J., Royston M. C., Reynolds G. P., and Cross A. J. (1989) Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52, 1781-1786.
8. Eastwood S. L., McDonald B., Burnet P. W., Beckwith J. P., Kerwin R. W., and Harrison P. J. (1995) Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 29, 211-223.
9. Eastwood S. L., Porter R. H., and Harrison P. J. (1996) The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain. Neurosci. Lett. 212, 163-166.
10. Eastwood S. L., Kerwin R. W., and Harrison P. J. (1997a) Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol. Psychiatry 41, 636-643.
11. Eastwood S. L., Burnet P. W. J., and Harrison P. J. (1997b) GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Mol. Brain. Res. 44, 92-98.
12. Fitzgerald L. W., Deutch A. Y., Gasic G., Heinemann S. F., and Nester E. F. (1995) Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15, 2453-2461.
13. Fuster J. M. (1980) The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. Raven Press, New York.
14. Goldman-Rakic P. S. (1987) Circuitry of the prefrontal cortex and the regulation of behavior by representational memory, in Handbook of Physiology (Plum F. and Mountcastle V., eds), pp. 373-417. American Physiological Society, Bethesda, Maryland.
15. Goldman-Rakic P. S. (1991) Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory, in Psychopathology and the Brain (Caroll B. F. and Barrett J. E., eds), pp. 1-13. Raven Press, New York.
16. Harrison P. J., McLaughlin D., and Kerwin R. W. (1991) Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337, 450-452.
17. Harrison P. J., Heath P. R., Eastwood S. L., Bumet P. W. J., McDonald B., and Pearson R. C. A. (1995) The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200, 151-154.
18. Hernandez I. and Sokolov B. P. (1997) Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics. Mol. Psychiatry 2, 57-64.
19. Hollmann M. and Heinemann S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
20. Javitt D. C. and Zukin S. R. (1991) Recent advances in phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301-1308.
21. Jentsch J. D., Redmond D. E. Jr., Elsworth J. D., Taylor J. R., Youngren K. D., and Roth R. H. (1997) Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277, 953-955.
22. Kamboj R. K., Schoepp D. D., Nutt S., Shekter L., Korczak B., True R. A., Rampersad V., Zimmerman D. M., and Wosnick M. A. (1994) Molecular cloning, expression, and pharmacological characterization of humEAA1, a human kainate receptor subunit. J. Neurochem. 62, 1-9.
23. Karp S. J., Masu M., Eki T., Ozawa K., and Nakanishi S. (1993) Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-D-aspartate receptor. J. Biol. Chem. 268, 3728-3733.
24. Kerwin R. W., Patel S., Meldrum B. S., Czudek C., and Reynolds G. P. (1988) Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet 1, 583-584.
25. Kerwin R. W., Patel S., and Meldrum B. S. (1990) Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39, 25-32.
26. 3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J. Neural Transm. 77, 231-236.
27. 3H] Amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics. J. Neurochem. 59, 829-837.
28. Levin S. (1984) Frontal lobe dysfunctions in schizophrenia. II: Impairments of psychological and brain functions. J. Psychiatry Res. 18, 27-55.
29. Ma Y. J., Costa M. E., and Ojeda S. R. (1994a) Developmental expression of the genes encoding transforming growth factor alpha and its receptor in the hypothalamus of female rhesus macaques. Neuroendocrinology 60, 346-359.
30. Ma Y. J., Hill D. F., Junier M. P., Costa M. E., Felder S. E., and Ojeda S. R. (1994b) Expression of epidermal growth factor receptor changes in the hypothalamus during the onset of female puberty. Mol. Cell. Neurosci. 5, 246-262.
31. Meador-Woodruff J. H., King R. E., Damask S. P., and Bovenkerk K. A. (1996) Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine. Mol. Psychiatry 1, 41-53.
32. Moghaddam B., Adams B., Verma A., and Daly H. (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17, 2921-2927.
33. Nash N. R., Heilman C. J., Rees H. D., and Levey A. I. (1997) Cloning and localization of exon 5-containing isoforms of the NMDAR1 subunit in human and rat brains. J. Neurochem. 69, 485-493.
34. Nutt S. L. and Kamboj R. K. (1994) RNA editing of human kainate receptor subunits. Neuroreport 5, 2625-2629.
35. Nutt S. L., Hoo K. H., Rampersad V., Deverill R. M., Elliott C. E., Fletcher E. J., Adams S. L., Korczak B., Foldes R. L., and Kamboj R. K. (1994) Molecular characterization of the human EAA5 (GluR7) receptor: a high-affinity kainate receptor with novel potential RNA editing sites. Receptors Channels 2, 315-326.
36. Olney J. W. and Farber N. B. (1995) Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52, 998-1007.
37. Olney J. W., Labruyere J., Wang G., Sesma M. A., Wozniak D. F., and Price M. T. (1991) NMDA antagonist neurotoxicity: mechanism and protection. Science 254, 1515-1518.
38. Ponte P., Ng S. Y., Engel J., Gunning P., and Kedes L. (1984) Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of human beta-actin cDNA. Nucleic Acids Res. 12, 1687-1696.
39. Porter R. H. P., Eastwood S. L., and Harrison P. J. (1996) Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res. 751, 217-231.
40. Puckett C., Gomez C. M., Korenberg J. R., Tung H., Meier T. J., Chen X. N., and Hood L. (1984) Molecular cloning and chromosomal localization of one of the human glutamate receptor genes. Proc. Natl. Acad. Sci. USA 88, 7557-7561.
41. Seeburg P. H. (1993) The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16, 359-365.
42. Sommer B., Keinanen K., Verdoorn T. A., Wisden W., Burnashev N., Herb A., Kohler M., Takagi T., Sakmann B., and Seeburg P. H. (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249, 1580-1585.
43. Stanta G. and Bonin S. (1998) RNA quantitative analysis from fixed and paraffin-embedded tissues: membrane hybridization and capillary electrophoresis. Biotechniques 24, 271-276.
44. Sugihara H., Moriyoshi K., Ishii T., Masu M., and Nakanishi S. (1992) Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 185, 826-832.
45. Tcherepanov A. A. and Sokolov B. P. (1997) Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics. J. Neurosci. Res. 49, 639-644.
46. Toyoda H., Takahata R., Inayama Y., Sakai J., Matsumura H., Yoneda H., Asaba H., and Sakai T. (1997) Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats. Neurochem. Res. 22, 249-252.
47. Ulas J. and Cotman C. W. (1993) Excitatory aminoacid receptors in schizophrenia. Schizophr. Bull. 19, 105-117.
48. Ulas J., Nguyen L., and Cotman C. W. (1993) Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport 4, 1049-1051.
49. Weinberger D. R. (1988) Schizophrenia and the frontal lobe. Trends Neurosci. 11, 367-370.
50. Weinberger D. R. (1993) A connectionist approach to the prefrontal cortex. J. Neuropsychiatry Clin. Neurosci. 5, 241-253.
51. Weinberger D. R., Aloia M. S., Goldberg T. E., and Herman K. F. (1994) The frontal lobes and schizophrenia. J. Neuropsychiatry Clin. Neurosci. 6, 419-427.
52. Werner P., Voigt M., Keinanen K., Wisden W., and Seeburg P. H. (1991) Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature 351, 742-744.
53. Young A. B. and Fagg G. E. (1990) Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol. Sci. 11, 126-133.
54. Zamorano P. L., Mahesh V. B., and Brann D. W. (1996) Quantitative RT-PCR for neuroendocrine studies. Neuroendocrinology 63, 397-407.